Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 149   

Articles published

BMY 49.18 -0.28 (-0.57%)
price chart
Bristol-Myers, Ono Collaborate To Develop Cancer Therapies
Bristol-Myers Squibb Co (BMY) and Ono Pharmaceutical Co., Ltd announced on Wednesday, that the two companies will jointly develop and commercialize selected compounds of monotherapy and combination regimens.
Bristol-Myers Squibb Co (BMY) Updates FY14 Earnings Guidance  Watch List News (press release)
BioMed Realty And Bristol-Myers Squibb Sign Lease To Expand Relationship To ...  MarketWatch
Related articles »  
Bristol-Myers Squibb Company : Bristol-Myers Squibb and Ono Pharmaceutical ...
NEW YORK & OSAKA, Japan--(BUSINESS WIRE)--Bristol-Myers Squibb Company(NYSE:BMY) and Ono Pharmaceutical Co., Ltd. ("Ono") have signed a strategic collaboration agreement to jointly develop and commercialize multiple immunotherapies as ...
Bristol-Myers Squibb's Second-Quarter Reflects a Company in Transition
Bristol-Myers Squibb (NYSE: BMY ) released its second-quarter earnings before the bell today, posting a non-GAAP EPS of $0.48 on $3.889 billion in revenue.
Bristol-Myers Beats Second-Quarter Estimates
Bristol-Myers Squibb Co (BMY) today reported second-quarter financial results for its fiscal 2014 before the markets opened.
Bristol-Myers Squibb taps Redwood City for expansion, cancer research hub
Bristol-Myers Squibb (NYSE: BMY), which could move into the lab and office facility after renovations are completed in early 2016, will add about 50 employees, said a company spokesman Thursday. BMS already has about 150 employees in Redwood City, ...
Bristol-Myers Squibb Company (NYSE:BMY) � Bristol-Myers Squibb Reports ...
Summary (NYSE:BMY) : Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Bristol-Myers Squibb Co (BMY) Releases FY14 Earnings Guidance
Bristol-Myers Squibb logo Bristol-Myers Squibb Co (NYSE:BMY) updated its FY14 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $1.70-1.80 for the period, compared to the Thomson Reuters consensus ...
Bristol-Myers Squibb Reports Second Quarter 2014 Financial Results
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today reported financial results for the second quarter of 2014, which was highlighted by strong global sales for the company's key brands; the achievement of important regulatory ...
Momentum Stocks: Bristol-Myers Squibb (NYSE:BMY), Coca-Cola Enterprises ...
Bristol-Myers Squibb Co (NYSE:BMY) [Trend Analysis] released its second quarter (Jun) earnings of $0.48 per share. The firm reaffirms outlook for FY14, sees EPS of $1.70-1.80 as compared to $1.78 Capital IQ Consensus Estimate.
Bristol-Myers Squibb Company's (BMY) CEO Lamberto Andreotti Q2 2014 ...
It was also significant for our company for Bristol-Myers Squibb. This was the first approval of our dual regimen anywhere world and this is the first time the first approval of one of our product and in fact two products at the same time occurred in ...